Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 299

1.

Impact of food challenge on local oesophageal immunophenotype in eosinophilic oesophagitis.

Philpott H, Lee SZ, Arrington A, McGee S, Dellon ES.

Clin Exp Allergy. 2020 Feb 3. doi: 10.1111/cea.13578. [Epub ahead of print]

PMID:
32012383
2.

Relationship Between Housing Components and Development of Eosinophilic Esophagitis.

Corder SR, Tappata M, Shaheen O, Cotton CC, Jensen ET, Dellon ES.

Dig Dis Sci. 2020 Jan 22. doi: 10.1007/s10620-020-06063-2. [Epub ahead of print]

PMID:
31970609
3.

Effect of Food Intake and Body Position on the Pharmacokinetics of Swallowed APT-1011, a Fluticasone Orally Disintegrating Tablet, in Healthy Adult Volunteers.

Comer GM, Bush MA, Dellon ES, Marino MT.

J Clin Pharmacol. 2020 Jan 15. doi: 10.1002/jcph.1572. [Epub ahead of print]

PMID:
31943257
4.

Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.

Bolton SM, Kagalwalla AF, Arva NC, Wang MY, Amsden K, Melin-Aldana H, Dellon ES, Bryce PJ, Wershil BK, Wechsler JB.

Am J Gastroenterol. 2020 Feb;115(2):224-233. doi: 10.14309/ajg.0000000000000474.

PMID:
31913192
5.

A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic Esophagitis.

Dellon ES, Guo R, McGee SJ, Hamilton DK, Nicolai E, Covington J, Moist SE, Arrington A, Wright BL, Burks AW, Vickery BP, Kulis M.

Clin Transl Gastroenterol. 2019 Dec;10(12):e00099. doi: 10.14309/ctg.0000000000000099.

6.

Correlation of endoscopic signs and mucosal alterations in children with eosinophilic esophagitis.

Hiremath G, Correa H, Acra S, Dellon ES.

Gastrointest Endosc. 2019 Nov 28. pii: S0016-5107(19)32481-2. doi: 10.1016/j.gie.2019.11.031. [Epub ahead of print]

PMID:
31785273
7.

Distal esophagus is the most commonly involved site for strictures in patients with eosinophilic esophagitis.

Eluri S, Tappata M, Huang KZ, Koutlas NT, Robey BS, Fan C, Reed CC, Shaheen NJ, Dellon ES.

Dis Esophagus. 2019 Nov 29. pii: doz088. doi: 10.1093/dote/doz088. [Epub ahead of print]

PMID:
31778150
8.

Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders.

Pesek RD, Reed CC, Collins MH, Muir AB, Fulkerson PC, Menard-Katcher C, Falk GW, Kuhl J, Magier AZ, Ahmed FN, Demarshall M, Gupta A, Gross J, Ashorobi T, Carpenter CL, Krischer JP, Gonsalves N, Hirano I, Spergel JM, Gupta SK, Furuta GT, Rothenberg ME, Dellon ES; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Dig Dis Sci. 2019 Nov 26. doi: 10.1007/s10620-019-05961-4. [Epub ahead of print]

PMID:
31773359
9.

The potential for malignancy from atopic disorders and allergic inflammation: A systematic review and meta-analysis.

Muir AB, Whelan KA, Dougherty MK, Aaron B, Navarre B, Aceves SS, Dellon ES, Jensen ET.

Clin Exp Allergy. 2020 Feb;50(2):147-159. doi: 10.1111/cea.13537. Epub 2019 Dec 20. Review.

PMID:
31743536
10.

Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure Prophylaxis.

Srinivas N, Cottrell M, Maffuid K, Prince HA, Nelson JAE, White N, Sykes C, Dellon ES, Madanick RD, Shaheen NJ, Gonzalez D, Kashuba ADM.

Antimicrob Agents Chemother. 2020 Jan 27;64(2). pii: e01729-19. doi: 10.1128/AAC.01729-19. Print 2020 Jan 27.

PMID:
31740561
11.

Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study.

Shoda T, Wen T, Caldwell JM, Collins MH, Besse JA, Osswald GA, Abonia JP, Arva NC, Atkins D, Capocelli KE, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Hirano I, Mukkada VA, Putnam PE, Sheridan RM, Rudman Spergel AK, Spergel JM, Wechsler JB, Yang GY, Aceves SS, Furuta GT, Rothenberg ME; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

J Allergy Clin Immunol. 2020 Jan;145(1):255-269. doi: 10.1016/j.jaci.2019.11.007. Epub 2019 Nov 16.

PMID:
31738990
12.

Emerging therapies for eosinophilic esophagitis.

Greuter T, Hirano I, Dellon ES.

J Allergy Clin Immunol. 2020 Jan;145(1):38-45. doi: 10.1016/j.jaci.2019.10.027. Epub 2019 Nov 6.

PMID:
31705907
13.

Oesophageal eosinophilia accompanies food allergy to hen egg white protein in young pigs.

Plundrich NJ, Smith AR, Borst LB, Snider DB, Käser T, Dellon ES, Blikslager AT, Odle J, Lila MA, Laster SM.

Clin Exp Allergy. 2020 Jan;50(1):95-104. doi: 10.1111/cea.13527. Epub 2019 Nov 26.

PMID:
31702085
14.

Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases.

Kim EM, Randall C, Betancourt R, Keene S, Lilly A, Fowler M, Dellon ES, Herfarth HH.

Inflamm Bowel Dis. 2019 Oct 21. pii: izz251. doi: 10.1093/ibd/izz251. [Epub ahead of print]

PMID:
31633167
15.

Rare Co-occurrence of Eosinophilic Esophagitis and Type 2B von Willebrand Disease: Implications for Endoscopic Surveillance and Esophageal Dilation.

Corder SR, Weston BW, Dellon ES.

ACG Case Rep J. 2019 May 14;6(5):e00069. doi: 10.14309/crj.0000000000000069. eCollection 2019 May.

16.

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.

Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A.

Gastroenterology. 2020 Jan;158(1):111-122.e10. doi: 10.1053/j.gastro.2019.09.042. Epub 2019 Oct 5.

17.

An Increasing Trend of Eosinophilic Esophagitis in Korea and the Clinical Implication of the Biomarkers to Determine Disease Activity and Treatment Response in Eosinophilic Esophagitis.

Kim GH, Park YS, Jung KW, Kim M, Na HK, Ahn JY, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Dellon ES, Jung HY.

J Neurogastroenterol Motil. 2019 Oct 30;25(4):525-533. doi: 10.5056/jnm19066.

18.

Geospatial distribution and characteristics of eosinophilic gastrointestinal disorder clinics in the United States.

Rukasin CRF, Hemler JA, Dellon ES, Curry-Johnson S, Hiremath G.

Ann Allergy Asthma Immunol. 2019 Dec;123(6):613-615. doi: 10.1016/j.anai.2019.09.019. Epub 2019 Sep 27. No abstract available.

PMID:
31568856
19.

Persistent Basal Cell Hyperplasia Is Associated With Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis.

Whelan KA, Godwin BC, Wilkins B, Elci OU, Benitez A, DeMarshall M, Sharma M, Gross J, Klein-Szanto AJ, Liacouras CA, Dellon ES, Spergel JM, Falk GW, Muir AB, Nakagawa H.

Clin Gastroenterol Hepatol. 2019 Sep 6. pii: S1542-3565(19)30977-2. doi: 10.1016/j.cgh.2019.08.055. [Epub ahead of print]

PMID:
31499251
20.

Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial.

Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, Gebhart JH, Galanko JA, Baron JA, Shaheen NJ.

Clin Gastroenterol Hepatol. 2019 Sep 6. pii: S1542-3565(19)30972-3. doi: 10.1016/j.cgh.2019.08.050. [Epub ahead of print]

PMID:
31499249

Supplemental Content

Loading ...
Support Center